Advertisement

Ads Placeholder
Loading...

Starpharma Holdings Limited

SPHRY•PNK
Healthcare
Biotechnology
$3.66
$0.26(7.65%)
U.S. Market opens in 5h 3m

Starpharma Holdings Limited (SPHRY) Stock Overview

Explore Starpharma Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap153.8M
P/E Ratio-225.90
EPS (TTM)$-0.05
ROE-0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$2.86
3 Months$3.70
1 Year Target$4.62

SPHRY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Starpharma Holdings Limited (SPHRY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.62.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -225.90 and a market capitalization of 153.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.50%
5-Day Change
7.82%
1-Month Change
16.03%
3-Month Change
40.58%
6-Month Change
81.84%
Year-to-Date (YTD) Change
40.58%
1-Year Change
519.49%
3-Year Change
23.90%
5-Year Change
-77.58%
All-Time (Max) Change
4.43%

Contact Information

https://starpharma.com
61 3 8532 2700
4-6 Southampton Crescent, Abbotsford, VIC, 3067

Company Facts

400 Employees
IPO DateMay 4, 2007
CountryAU
Actively Trading

Frequently Asked Questions